Multi-modal prehabilitation: addressing the why, when, what, how, who and where next?

Faculty development: who, what, why, where, when, and how?

Developing people — helping them become more capable, conscientious, and confident — is the fundamental mission of any academic institution. It is what they do and why they exist. At health professions colleges and schools, faculty members spend much of their time communicating the accumulated knowledge, skills, and values of the profession and providing structured opportunities for learners to...

Agents, Multi-Agent Systems and Declarative Programming: What, When, Where, Why, Who, How?

This chapter tackles the relation between declarative languages and multi-agent systems by following the dictates of the five Ws (and one H) that characterize investigations. The aim is to present this research field, which has a long-term tradition, and discuss about its future. The first question to answer is “What? What are declarative agents and multi-agent systems?”. Therefore, we will int...

The Why, Who, What, How, and When of Patient Engagement in Healthcare Organizations: A Response to Recent Commentaries

Genetic and Evolutionary Computation: Who, What, Where, When, and Why

In this paper, we start by providing a gentle introduction to the field of genetic and evolutionary computation, particularly focusing on genetic algorithms, but also touching upon other areas. We then move on to briefly analyse the geographic distribution of research excellence in this field, focusing our attention specifically on Italian researchers. We then present our own interpretation of ...

AL amyloidosis: who, what, when, why, and where.

Since the first reports of amyloid being “cellulose” (reported by Virchow in the mid-1850s) and the identification of amyloid fibril ultrastructure in the late 1950s, amyloidosis has remained an enigmatic disease. However, progress in our ability to diagnose and treat amyloidosis has advanced tremendously in recent years. The use of chemotherapy and immunomodulatory agents has changed AL amyloi...